CBI Scene Blog

How Genetics Advancements Are Paving Way for Opportunities in Rare Disease Research, Diagnosis & Treatment

Posted by Chelsea A on Jul 29, 2014 11:21:00 AM

Genetics have increased disease control and reduction likelihoods, and this is just the beginning. The lines have been pushed through newborn screening. More than ever, genetic testing has reached new heights.

Read More

Topics: patient adherence, Patient Access, Rare Disease & Orphan Drugs

An Analysis on Effectiveness Evidence in FDA's Approval of Orphan Drugs

Posted by Stephanie V on Jun 20, 2014 2:08:00 PM

 

The FDA has a commitment to getting products to treat orphan diseases on the market as quickly as possible. Some of the people who have these diseases have no o

ther options for treatment, and a new drug could offer them their only hope of survival.

Read More

Topics: patient adherence, Patient Access, Patient Assistance, Rare Disease & Orphan Drugs

eCoupons Offer Adherence and Patient Engagement Opportunities

Posted by Ken Kark on Jun 13, 2014 11:25:00 AM

McKesson Patient Relationship Solutions (MPRS) is pleased to have been named a finalist in the 9th Annual Strategic Patient Adherence Awards, dedicated to recognizing excellence and advances in patient adherence. In advance of the Patient Adherence and Access Summit (PAAS), we wanted to preview the “Coupon Integration and Tracking within e-Prescribing Workflow” program, which was designed to provide brands with co-pay offset programs delivered through physicians’ e-Prescribing/EHR systems to patients at the point of prescribing.

Read More

Topics: Brand & Digital Strategy, patient adherence, Patient Access, Patient Assistance

How to Solve Patient Retention & Compliance Problems with Patient Reminders

Posted by Mark Taggart on Oct 8, 2013 12:32:00 PM

Read More

Topics: patient adherence, Clinical

Speed to Therapy: A 5K Dash to Therapy Initiation

Posted by Brittany Lake on May 20, 2013 2:37:00 PM

Read More

Topics: Commercial & Patient Programs, patient adherence, Patient Access, speed to therapy